TrialNeuro-oncology2017

Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.

Patrick Grossmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.